ストックスクリーナーアプリを入手
36.56
1.45%
0.735
前日終値:
$37.30
開ける：
$37.06
24時間の取引高:
4.74M
Relative Volume:
1.23
時価総額：
$16.36B
収益：
$2.31B
当期純損益:
$1.66B
株価収益率:
15.92
EPS:
2.297
ネットキャッシュフロー:
$827.02M
1週間 パフォーマンス:
+3.93%
1か月 パフォーマンス:
+4.91%
6か月 パフォーマンス:
+15.05%
1年 パフォーマンス:
+39.12%
1日の値動き範囲:
$36.76
$38.09
1週間の範囲:
$36.23
$38.09
52週間の値動き範囲:
$24.05
$38.09
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
37.84 | 16.12B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 107.10B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | 開始されました | Goldman | Buy |
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Royalty Pharma Q3 Profit Falls - Nasdaq
Royalty Pharma Reports Third Quarter 2025 Results - TradingView
Historical volatility pattern of Royalty Pharma plc visualizedJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Homestead Advisers Corp Purchases 8,300 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Why analysts remain bullish on Royalty Pharma plc stock2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
Is Royalty Pharma plc (RPD) stock attractive post correctionWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Quantitative breakdown of Royalty Pharma plc recent moveTrade Risk Assessment & Weekly High Momentum Picks - newser.com
Can Royalty Pharma plc stock rebound after recent weaknessM&A Rumor & Technical Entry and Exit Alerts - newser.com
Top chart patterns to watch in Royalty Pharma plcDay Trade & Real-Time Market Trend Scan - newser.com
Royalty Pharma stock hits 52-week high at 38.01 USD By Investing.com - Investing.com Nigeria
Is Royalty Pharma plc reversing from oversold territoryDividend Hike & Low Risk Investment Opportunities - newser.com
What’s the recovery path for long term holders of Royalty Pharma plc2025 Technical Overview & Reliable Volume Spike Alerts - newser.com
How Royalty Pharma plc (RPD) stock performs in easing cycles2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
Will Royalty Pharma plc (RPD) stock maintain strong growth - newser.com
Royalty Pharma acquires AMVUTTRA royalty interest for $310 million By Investing.com - Investing.com Nigeria
Royalty Pharma Plc Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Royalty Pharma stock hits 52-week high at 38.01 USD - Investing.com
Royalty Pharma acquires AMVUTTRA royalty interest for $310 million - Investing.com
Royalty Pharma Acquires $310 Million Royalty Interest in Alnylam's AMVUTTRA from Blackstone Life Sciences - Quiver Quantitative
Royalty Pharma acquires AMVUTTRA royalty for $310 million - StreetInsider
Royalty Pharma (NASDAQ: RPRX) acquires 1% AMVUTTRA royalty for $310M from Blackstone - Stock Titan
Using Python tools to backtest Royalty Pharma plc strategies2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
Corton Capital Inc. Acquires New Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Applying chart zones and confluence areas to Royalty Pharma plcMarket Performance Report & Fast Gain Swing Trade Alerts - newser.com
Royalty Pharma PLC $RPRX Shares Purchased by Strs Ohio - MarketBeat
What To Expect From Royalty Pharma’s (RPRX) Q3 Earnings - Yahoo! Finance UK
Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's 3rd Largest Position - MarketBeat
Tredje AP fonden Increases Stake in Royalty Pharma PLC $RPRX - MarketBeat
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsJobs Report & Weekly Breakout Opportunity Watchlist - newser.com
Is Royalty Pharma plc stock a top momentum playWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
What the charts say about Royalty Pharma plc today2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com
Why Royalty Pharma plc (RPD) stock could outperform next year2025 Technical Overview & Safe Entry Trade Signal Reports - newser.com
Why Royalty Pharma plc (RPD) stock could rally stronglyStock Surge & Long-Term Safe Investment Plans - newser.com
What MACD signals say about Royalty Pharma plcMarket Movement Recap & Low Risk Investment Opportunities - newser.com
8,849 Shares in Royalty Pharma PLC $RPRX Acquired by MMA Asset Management LLC - MarketBeat
Royalty Pharma PLC $RPRX is Regal Partners Ltd's 9th Largest Position - MarketBeat
Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Reliable Intraday Trade Plans - newser.com
Royalty Pharma plc : Close to an important technical resistance levels - MarketScreener
Can Royalty Pharma plc stock beat analyst upgradesProfit Target & Fast Gain Swing Trade Alerts - newser.com
Detecting support and resistance levels for Royalty Pharma plcMarket Trend Report & Fast Entry Momentum Alerts - newser.com
28,646 Shares in Royalty Pharma PLC $RPRX Bought by Nisa Investment Advisors LLC - MarketBeat
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
0.86%
大文字化:
|
ボリューム (24 時間):